Study of Intermittent OSI-906 Dosing

Clinical trial NCT00514306 · COMPLETED

Trial details

NCT number: NCT00514306
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2007-07-05
Primary completion: 2010-09-20
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.